Status:
UNKNOWN
Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Bullous Pemphigoid
Pruritus
Eligibility:
All Genders
Brief Summary
The following is the investigators hypothesis regarding the pruritus of BP patients during remission. Anti-BP 180 IgE binds to dermal mast cells, inducing their activation and secretion of mediators a...
Detailed Description
Bullous pemphigoid(BP) is a cutaneous autoimmune blister disease. In addition to blisters formation which disrupt skin barrier and result in high mortality, erythematous edematous plaques often develo...
Eligibility Criteria
Inclusion
- Patients with bullous pemphigoid
Exclusion
- Patients have other disorders which can lead to itching sensation
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01265082
Start Date
December 1 2010
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, National Taiwan University Hospital
Taipei, Taiwan